Harmony Biosciences Holdings, Inc.
Pitolisant
Prader-Willi Syndrome (PWS)
Countdown
177days
Phase 3 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 3 trial results for Pitolisant in Prader-Willi Syndrome (PWS) are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“On track with PWS Phase 3 data 2H 2026”